Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.75
-2.71 (-15.52%)
At close: Dec 5, 2025, 4:00 PM EST
14.79
+0.04 (0.27%)
After-hours: Dec 5, 2025, 7:58 PM EST
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
According to 10 professional analysts, the 12-month price target for Adaptive Biotechnologies stock ranges from a low of $10 to a high of $21. The average analyst price target of $16.6 forecasts a 12.54% increase in the stock price over the next year.
Price Target: $16.60 (+12.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Adaptive Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 9 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $11 → $16 | Hold | Maintains | $11 → $16 | +8.47% | Nov 11, 2025 |
| BTIG | BTIG | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | +42.37% | Nov 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +35.59% | Nov 6, 2025 |
| BTIG | BTIG | Strong Buy Maintains $14 → $19 | Strong Buy | Maintains | $14 → $19 | +28.81% | Oct 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | +35.59% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
269.89M
from 178.96M
Increased by 50.81%
Revenue Next Year
273.04M
from 269.89M
Increased by 1.17%
EPS This Year
-0.50
from -1.08
EPS Next Year
-0.59
from -0.50
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 280.1M | 289.3M | |||
| Avg | 269.9M | 273.0M | |||
| Low | 257.7M | 250.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 56.5% | 7.2% | |||
| Avg | 50.8% | 1.2% | |||
| Low | 44.0% | -7.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.48 | -0.54 | |||
| Avg | -0.50 | -0.59 | |||
| Low | -0.50 | -0.64 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.